NPF Peptide

Protein Family: Receptors and Channels, Protein Kinases

Pathway and Disease: Metabolic Disorders, cell communication, Endocrine System, Membrane Transport

Alternate Names: Insulin receptor; EC 2.7.10.1; IR; CD220 antigen; INSR

Accession No.: P06213

Description:
The NPF peptide encompasses the tyrosine-1355 (Y1355) phosphorylation site within the insulin receptor. This is an autocatalytic site for insulin receptor tyrosine-protein kinase activity.

Format:
Each vial contains 1 mg of lyophilized solid packaged under an inert gas and supplied as a trifluoroacetate salt.

MW: 1238.25 g/mol

Sequence:
Human: H-Lys-Arg-Ser-Tyr(PO3H2)-Glu-Glu-His-Ile-Pro-OH or H-KRSY(PO3H2)EEHIP-OH

Composition:
C51H80N15O19P

Purity:
> 95% by HPLC

Solubility:
Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile.

Storage:
Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, aliquot and store at -20°C.